News Aethlon Medical, Inc.

Equities

AEMD

US00808Y4061

Delayed Nasdaq Other stock markets 12:48:59 2024-04-25 pm EDT			5-day change	1st Jan Change
1.503 ^USD	-1.76%		+6.22%	-31.37%

Feb. 14	Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
Feb. 14	Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aethlon Medical : Corporate Presentation April 2024	08:38am	PU
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices	Feb. 21	PR
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024	Feb. 14
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update	Feb. 14	PR
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024	Feb. 07	PR
Transcript : Aethlon Medical, Inc., Q2 2024 Earnings Call, Nov 14, 2023	Nov. 14
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update	Nov. 14	PR
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer	Nov. 13	PR
Aethlon Medical, Inc Announces Executive Changes	Nov. 13	CI
Aethlon Medical, Inc. Announces Appointment Ofguy Ciprian as Chief Operating Officer	Nov. 13	CI
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023	Nov. 06	PR
HC Wainwright Adjusts Price Target on Aethlon Medical to $23 From $90, Maintains Buy Rating	23-10-24	MT
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	23-10-10	CI
Reverse Split: 1 of 10	23-10-04	FA
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split	23-10-04	MT
Aethlon Announces Reverse Stock Split	23-10-04	PR
Aethlon Medical : September 2023 Aethlon Presentation for HC Wainwright Financial Conference	23-09-12	PU
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-08-30	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aethlon Medical, Inc.

Equities

AEMD

US00808Y4061

Summary

Filters